SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending as community discussion amplifies around its strategic pivot and hiring for robotics AI, underscoring its pivotal role in training artificial intelligence for the burgeoning humanoid and physical AI sectors, further bolstered by its significant partnership with Palantir and strong anticipation for its upcoming earnings.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending amid its Robinhood listing and strategic moves to integrate Real World Assets with NestCredit and implement PYTH Reserve token purchases. The community is actively debating its potential as a leading oracle solution, often comparing it to Chainlink, while also discussing concerns about token distribution and upcoming unlocks.

Royal Gold, Inc. engages in the business of acquiring and managing precious metal streams, royalties, and similar interests. It operates under the Acquisition and Management of Stream Interests, and Acquisition and Management of Royalty Interests segments. The Acquisition and Management of Stream Interests segment focuses on metal streams, which are purchase agreements that provide, in exchange for an upfront deposit payment, the right to purchase all or a portion of one or more metals produced, at a price determined for the life of the transaction. The Acquisition and Management of Royalty Interests segment is involved in non-operating interests in mining projects that provide the right to revenue or metals produced from the project. The company was founded by Stanley Dempsey in 1981 and is headquartered in Denver, CO.

Royal Gold, Inc.

Royal Gold is trending as gold and silver prices reach new highs, with the community calling it a "money printer" due to its robust streaming model. The recent strategic acquisition of Sandstorm Gold, set to significantly boost GEO production and diversify its portfolio, fuels bullish sentiment despite varied analyst price target adjustments.

Tidal Trust II - YieldMax Ultra Short Option Income Strategy ETF

SLTY is drawing attention from high-yield investors as a component of mechanical, 'inverted pair' strategies within the YieldMax ETF suite, valued for its consistent weekly dividends generated from option premiums. The community is actively discussing its utility as a potential bear market hedge and its performance in disciplined, rules-based systems focused on compounding and reinvestment.

Tidal Trust II - YieldMax Short NVDA Option Income Strategy ETF

YieldMax Short NVDA Option Income Strategy ETF

YieldMax Short NVDA Option Income Strategy ETF (DIPS) is trending as investors evaluate its recent dividend payouts and performance in response to NVIDIA's price action and market volatility. The community is actively discussing DIPS for its role in 'inverted pair' hedging strategies and as a high-yield option to gain exposure to potential NVDA downturns or balance existing bullish positions, amidst ongoing conversations about managing its inherent NAV decay.

Tidal Trust II - YieldMax COIN Option Income Strategy ETF

YieldMax COIN Option Income Strategy ETF

YieldMax COIN Option Income Strategy ETF (CONY) is trending as it transitions to weekly dividend distributions, a move that is intensifying community debate around persistent NAV erosion and recent reverse splits, even as some investors advocate for disciplined, long-term income compounding strategies amidst underlying Coinbase volatility.

Tidal Trust II - YieldMax Short COIN Option Income Strategy ETF

YieldMax Short COIN Option Income Strategy ETF

FIAT is trending as investors keenly observe its performance as a YieldMax ETF designed to short Coinbase, often utilized in inverted pair strategies for income generation. The community is actively discussing its latest dividend payouts and debating its effectiveness as a hedge against crypto market volatility, with some anticipating buying opportunities on price dips.

Tidal Trust II - YieldMax NVDA Option Income Strategy ETF

YieldMax NVDA Option Income Strategy ETF

NVDY is trending as investors evaluate its high, fluctuating dividend payouts amidst persistent share price erosion, even with NVIDIA's underlying strength. Community discussion centers on whether reinvesting the recently shifted smaller weekly dividends can effectively counter capital loss and ensure long-term viability.

Tidal Trust II - YieldMax MSTR Short Option Income Strategy ETF

YieldMax MSTR Short Option Income Strategy ETF

WNTR is trending as a favored inverse YieldMax ETF, offering robust dividends while hedging against downward moves or volatility in MicroStrategy (MSTR) and Bitcoin. The community is actively discussing its 'sweet' weekly payouts, especially as a strategic component in 'inverted pairs' with MSTY, allowing for income generation and portfolio balancing through disciplined, options-driven compounding during varied market conditions.

Nova Minerals Ltd. engages in the exploration and development of mineral properties. Its projects include Estelle Gold, RPM, Korbel, Train, Stoney and Studies projects. The company was founded in January 1987 and is headquartered in Melbourne, Australia.

Nova Minerals Limited - ADR

Nova Minerals is trending as it moves to redomicile in the United States, a strategic shift anticipated to attract institutional investors and US ETFs to its Estelle Gold and Critical Minerals Project. Community enthusiasm is also driven by its key antimony resources, backed by a significant government grant for US defense needs, and an upcoming forward stock split, all fueling discussions of its long-term potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Factors You Need to Know Ahead of ProPetro's Q4 Earnings Release

PUMP heads into Q4 earnings with revenues expected to fall 11.6% year over year and estimates calling for a 13-cent loss.

Should You Buy Axsome Therapeutics Stock Before Feb. 23?

Key PointsAxsome got a big boost late last year after regulators granted priority review for its Alzheimer's drug...

Principal Financial Group Inc. Acquires 12,923 Shares of Axsome Therapeutics, Inc. $AXSM

Principal Financial Group Inc. grew its stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 3.6% in the third quarter, according to its most recent disclosure with the...

Axsome Therapeutics (NASDAQ:AXSM) Given New $245.00 Price Target at Jefferies Financial Group

Jefferies Financial Group boosted their price objective on Axsome Therapeutics from $200.00 to $245.00 and gave the company a "buy" rating in a report on Tuesday...

Axsome Therapeutics (NASDAQ:AXSM) CEO Herriot Tabuteau Sells 32,410 Shares

Axsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report) CEO Herriot Tabuteau sold 32,410 shares of Axsome Therapeutics stock in a transaction that occurred on Monday, February 2nd. The stock was...

Leerink Partners Issues Positive Forecast for Axsome Therapeutics (NASDAQ:AXSM) Stock Price

Leerink Partners upped their price objective on Axsome Therapeutics from $150.00 to $205.00 and gave the company an "outperform" rating in a research report on Wednesday...

Auvelity Continues to Aid AXSM's Top Line: More Upside in 2026?

Axsome's Auvelity delivered robust 2025 sales growth. A pending FDA decision in 2026 could unlock a broader market and drive sales further.

Universal Beteiligungs und Servicegesellschaft mbH Increases Position in Axsome Therapeutics, Inc. $AXSM

Universal Beteiligungs und Servicegesellschaft mbH increased its holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) by 30.7% during the 3rd quarter, according to the company in its...

Cabot Wealth Management Inc. Buys Shares of 5,560 Axsome Therapeutics, Inc. $AXSM

Cabot Wealth Management Inc. purchased a new stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) during the 3rd quarter, according to its most recent 13F filing with the...

FY2025 Earnings Forecast for AXSM Issued By HC Wainwright

Axsome Therapeutics, Inc. (NASDAQ:AXSM - Free Report) - Equities research analysts at HC Wainwright lifted their FY2025 EPS estimates for shares of Axsome Therapeutics in a research note issued on...

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Current Price	$181.21
Prev Close	$182.94
Open	$183.35
Dividend Yield	0.00%
50-Day Moving Average	$168.89
Beta	0.74
Avg. Volume	767,322.80
PE Ratio	-38.77

52-Week High	$191.50
52-Week Low	$86.99
Market Capitalization	$9.14B
EPS (Annual)	-$5.99
Price to Book	123.65
Revenue Per Employee	$564,704.25

AXSM
Axsome Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AXSM News

AXSMAxsome Therapeutics Inc